Outsourced Pharma App Notes & Case Studies

31. Ultra-Low Cross-Linked Microgel Purification 2/24/2026

    ULC microgel purification is often slowed by linear polymer contamination and limitations of centrifugation. Explore how hollow fiber TFF improves filtration efficiency and supports scalable processing.

32. Application Of A Dual Spiking Strategy In Viral Clearance Studies 2/3/2026

    Explore how an alternative spiking strategy can streamline viral clearance studies, reduce material demands, and maintain compliance while addressing the challenges posed by MLV and MMV.

33. Providing Packing And Blinding Solutions For An Innovative Drug Start-Up 9/13/2024

    Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.

34. Overcoming The Solubility Challenges Of Antibody-Drug Conjugates 6/3/2024

    Discover a chito-oligosaccharide that significantly improves the solubility of antibody-drug conjugates (ADCs) when included in the linker-payload construct.

35. Asset Reinduction To Maximo EAM, Enabled By Reality Capture 2/11/2025

    Find out how reality capture was used to create a digital twin 750,000-square-foot Pfizer campus to support asset reinduction to Maximo EAM, saving Pfizer 3,000 hours per year.

36. Virus Retention Performance Under Diverse Processing Conditions 11/14/2025

    Virus filtration is robust across a wide range of process parameters, including high protein concentration and flow decay. Discover how retention relies on size exclusion to simplify risk assessment.

37. Scale-Up Of AAV Production In Fixed-Bed Bioreactors 3/31/2026

    Consistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.

38. WuXiHigh 2.0 Delivers A 180 mg/mL Formula 3/26/2026

    This case study shows how smart formulation and integrated development achieved a stable 180 mg/mL biologic for subcutaneous delivery, for teams tackling concentration issues.

39. Avoid CapEX With Improved Operational Efficiencies 1/14/2026

    Avoid massive capital expenditures by optimizing supply chain logistics. Learn how off-site material sampling and just-in-time delivery reduce lead times from eight weeks to a single day.

40. Use Of Reconstructed Tissue And 3D Printed CT-Based Nasal Casts 7/3/2025

    Reconstructed nasal epithelium and CT-based 3D nasal casts provide more predictive, physiologically relevant models for assessing nasal drug delivery, improving accuracy in formulation development.